Atlas Trials

MAIC of Fruquintinib Plus Paclitaxel Versus Ramucirumab Plus Paclitaxel in Advanced G/GEJ Adenocarcinoma

Clinical trial NCT07144995 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07144995
Sponsor
Sun Yat-sen University
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Advanced Gastric CancerGastroesophageal Junction AdenocarcinomaFruquintinibRamucirumab
Start date
2025-09-05
Primary completion
2026-08-05
Enrollment
1143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.